Ashley Spinale

Ashley Spinale is an experienced professional in gene and cell therapy operations, currently serving as Associate Director of Gene Therapy Operations at bluebird bio since March 2022, previously holding the role of Sr. Manager for Zynteglo and Skysona. Prior to this, Ashley contributed to Medeor Therapeutics, Inc. from February 2018 to January 2024 in various roles, ultimately as Associate Director of Cell Therapy and Clinical Logistics. Ashley's experience also includes roles at Stanford Health Care and Stanford Blood Center, focusing on apheresis operations and training. Ashley holds a Bachelor of Science in Business Administration with a concentration in Marketing from San Jose State University.